The significant differences in blood NfL between the PD and APD groups were not affected when additionally controlling for disease duration (PSP, p = 0.011; MSA, p = 0.002; CBS, p < 0.001). This evidence concerns the gene CBS and supranuclear palsy, progressive, 1.